The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study.

about

Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention Dopamine agonists for preventing ovarian hyperstimulation syndrome.Metformin improves ovarian follicle dynamics by reducing theca cell proliferation and CYP-17 expression in an androgenized rat model.

P2860

Q26827593-E09C953E-65E8-434F-AB14-14E47D3D27DC Q34546236-7E560F44-938D-4AC4-965A-FC7BB34B6DB0 Q51737343-AD7C3523-8DBD-443D-A95F-98C2C3416644

P2860

The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study.

Item

http://www.wikidata.org/entity/Q55056870

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

The effects of bromocriptine o ...... ation patients: a pilot study.

@en

The effects of bromocriptine o ...... ation patients: a pilot study.

@nl

type

Item

label

The effects of bromocriptine o ...... ation patients: a pilot study.

@en

The effects of bromocriptine o ...... ation patients: a pilot study.

@nl

prefLabel

The effects of bromocriptine o ...... ation patients: a pilot study.

@en

The effects of bromocriptine o ...... ation patients: a pilot study.

@nl

P1476

The effects of bromocriptine o ...... ation patients: a pilot study.

@en

P2093

Ana Lúcia Beltrame

http://www.w3.org/2001/XMLSchema#string

Edmund C Baracat

http://www.w3.org/2001/XMLSchema#string

Paulo Serafini

http://www.w3.org/2001/XMLSchema#string

P2860

Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.

The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome

Current treatment issues in female hyperprolactinaemia.

GnRH agonists vs antagonists.

Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.

Preventing ovarian hyperstimulation syndrome: guidance for the clinician.

Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome.

GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study.

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.

Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.

P304

201-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09513590.2012.736554

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo L. Motta

José Maria Soares

P577

2012-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23167783

http://www.w3.org/2001/XMLSchema#string

The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study.

about

P2860

P2860

The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698